- Few Southeast students face suspension, expulsion for sexual assaults, campus paper finds (4/25/17)5
- Pilot House goes smoke-free (4/23/17)10
- Woman battered after smashing boyfriend's meth pipe against wall, police say (4/25/17)1
- Event includes the first public tour of 200-year-old Elmwood Manor (4/23/17)3
- BBB warns Jackson man's online business might not be legit (4/24/17)
- Cape councilman Bob Fox to run for mayor (4/21/17)5
- Cape couple turns their home into cozy, comfortable music venue (4/24/17)
- Perryville family organizing bone-marrow drive Friday for ailing 6-year-old boy (4/26/17)
- Without city record, Marie Street residents on hook for thousands in sewer repairs (4/19/17)7
- Sikeston man charged in shooting death of Cape man (4/23/17)
Anti-depressant may counter shrinkage in brain
WASHINGTON -- Major depression makes an important part of the brain actually shrink. Stress seems to be a suspect, but no one knows how to stop or reverse the atrophy.
Now a new study of primates' brains says a European anti-depressant seems to counter the shrinkage -- raising calls for more research to see if other medications might help people, too.
"These are impressive and important findings," said Dr. Robert Sapolsky of Stanford University, who reviewed the new research.
But, "mind you, this is one anti-depressant and this is a fairly atypical one" compared to the antidepressants most Americans use, Sapolsky cautioned.
German researchers tested a new anti-depressant sold only in Europe called tianeptine. The antidepressants most popular in the United States work by blocking the dissipation of a neurotransmitter called serotonin that's important for mood. Tianeptine does exactly the opposite.
20 percent smaller
Major, long-term depression can cause a brain region called the hippocampus to shrink, in some cases nearly 20 percent. The hippocampus is important for learning and memory, so that probably explains why memory loss often accompanies depression. And the region doesn't seem to bounce back after the depression is cured.
Nobody knows exactly why this atrophy occurs: Neurons may die or shrink, or ones that should have been born to replenish the region may not be. Whichever, it does seem linked to a stress hormone called cortisol, because about half of seriously depressed patients secrete too much cortisol.
To see if tianeptine could help, neurobiologist Eberhard Fuchs and colleagues at the German Primate Center tested tree shrews, who exhibit a classic model for human depression when exposed to social stress.
Over a 35-day period, depressed shrews experienced excess cortisol, decreased amounts of brain chemicals important for healthy cells, a 33 percent decrease in new cell growth and a 7 percent decline in hippocampal volume. But shrews that were given oral tianeptine saw their brain chemical concentrations return to normal, cell growth restart and the hippocampus return to its pre-depression size.